Twitter with us!

Article

Ophthalmology Times Europe is now on Twitter (twitter.com/OTEurope).

Ophthalmology Times Europe is now on Twitter.

For all the breaking news and latest updates, follow us on twitter.com/OTEurope. You can tweet with the OTE team, and let us know your thoughts on all the latest stories.

If you would like to have longer discussions or network with your peers, join our European Ophthalmology forum by going to oteurope.com/forum.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
Related Content
A cell being injected by a syringe. Image credit: ©Corona Borealis – stock.adobe.com

Trinity team’s gene therapy offers promising glaucoma and AMD treatment

Martin David Harp
September 9th 2024
Article

Research by investigators at Trinity College in Dublin, Ireland shows how the gene therapy conferred significant protection for retinal ganglion cells

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A doctor uses the iCare ST500 with a patient. Image courtesy of iCare.

iCare debuts slit-lamp-mounted ST500 tonometer

Hattie Hayes
September 9th 2024
Article

The Finnish company shared technical specifications for the ST500

A woman driving at night touches her eye. Image credit: ©Drazen – stock.adobe.com

ESCRS 2024: A new EDOF IOL brings functional outcomes into the spotlight

Hattie Hayes
September 7th 2024
Article

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

A magnet sits in a pile of iron filings. Image credit: ©New Africa – stock.adobe.com

Magnetic cell therapy for corneal endothelial dysfunction

By Lynda Charters; Reviewed by Sumit Garg, MD, ABO
September 6th 2024
Article

Phase 1 multicentre study data demonstrate early signs of efficacy

Miniature figures with backpacks stand on a map of Europe. Image credit: ©kirill_makarov – stock.adobe.com

Unite and conquer: Refractive surgery goes on a world tour

Hattie Hayes
September 4th 2024
Article

The ESCRS Moving Simulator initiative brings surgical training to nations in need

© 2024 MJH Life Sciences

All rights reserved.